Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Insulin Isophane (NPH) With Insulin Glargine in New Onset Diabetes After Transplant (NODAT)

NCT01963728 is registered in ClinicalTrials.gov with Inova Health Care Services as lead sponsor.

NCT NCT01963728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01963728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Insulin Isophane (NPH) With Insulin Glargine in New Onset Diabetes After Transplant (NODAT)
Lead sponsor
Inova Health Care Services
Phase
Phase 4
Overall status
Terminated
Start date
November 27, 2013
Completion date
April 9, 2015
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus